CareDx (CDNA)
(Delayed Data from NSDQ)
$8.95 USD
+0.12 (1.36%)
Updated Mar 24, 2023 04:00 PM ET
After-Market: $8.96 +0.01 (0.11%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
CareDx (CDNA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$18.00 | $24.00 | $9.00 | 103.85% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for CareDx comes to $18.00. The forecasts range from a low of $9.00 to a high of $24.00. The average price target represents an increase of 103.85% from the last closing price of $8.83.
Analyst Price Targets (6 )
Broker Rating
CareDx currently has an average brokerage recommendation (ABR) of 1.86 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.33 a month ago based on six recommendations.
Of the seven recommendations deriving the current ABR, four are Strong Buy, representing 57.14% of all recommendations. A month ago, Strong Buy represented 83.33%.
Broker Rating Breakdown

Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.86 | 1.86 | 1.33 | 1.33 | 1.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | From | To |
---|---|---|---|---|
3/3/2023 | Raymond James | Andrew Cooper | Strong Buy | Hold |
3/3/2023 | Craig-Hallum | Alex Nowak | Strong Buy | Hold |
12/4/2022 | Jefferies & Co. | Brandon Couillard | Not Available | Strong Buy |
11/7/2022 | Btig | Mark Massaro | Not Available | Strong Buy |
11/4/2022 | H C Wainwright | Yi Chen | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.86 |
ABR (Last week) | 1.86 |
# of Recs in ABR | 7 |
Average Target Price | $18.00 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 144 of 252 |
Current Quarter EPS Est: | -0.07 |